Literature DB >> 10098961

Expression of ICAM-1 and CD11b after experimental spinal cord injury in rats.

J Isaksson1, M Farooque, A Holtz, L Hillered, Y Olsson.   

Abstract

We have performed an immunohistochemical study on the expression of the adhesion molecules ICAM-1 and CD11b 1 h to 1 week following a compression injury to the rat spinal cord. The spinal cord of control animals showed ICAM-1 expression in some vessels and in the leptomeninges. Mechanical compression of the spinal cord induced an endothelial upregulation of ICAM-1 that was maximal in rats surviving 1-2 days after injury. This reaction was seen at the center of the lesion as well as in the perifocal zones. Apart from the endothelial upregulation, increased ICAM-1 expression also was found in leptomeningeal and ependymal cells of traumatized animals. In control animals resting microglial cells were moderately CD11b immunoreactive. Trauma induced a rapid microglial upregulation of CD11b in the white matter that was evident even at 1 h after injury. By 1 day to 1 week posttrauma conformational changes consistent with microglial activation, i.e., transformation into phagocytic microglial cells, were seen in the white matter. In the gray matter, CD11b immunohistochemistry revealed massive infiltration of phagocytic microglial cells and macrophages in animals surviving 1 day to 1 week. Intravascular and infiltrating leukocytes were intensely CD11b immunopositive. As reflected by CD11b immunohistochemistry, the maximal infiltration of polymorphonuclear leukocytes occurred at 2 days after the insult. Endothelial upregulation of ICAM-1 facilitates adhesion and extravasation of leukocytes by binding to the counterreceptor CD11b. Knowledge regarding the expression and cellular distribution of such molecules after central nervous system trauma is important since inflammatory mechanisms have been suggested to be involved in secondary neurological damage and thus constitute potential targets of therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098961     DOI: 10.1089/neu.1999.16.165

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  6 in total

Review 1.  Cell cycle activation and spinal cord injury.

Authors:  Junfang Wu; Bogdan A Stoica; Alan I Faden
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

Review 2.  Glial and axonal regeneration following spinal cord injury.

Authors:  Sei Shibuya; Tetsuji Yamamoto; Toshifumi Itano
Journal:  Cell Adh Migr       Date:  2009-01-07       Impact factor: 3.405

3.  Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis.

Authors:  Cecile Canova; Jim W Neal; Philippe Gasque
Journal:  J Neuroinflammation       Date:  2006-09-02       Impact factor: 8.322

4.  Evaluation of Injured Axons Using Two-Photon Excited Fluorescence Microscopy after Spinal Cord Contusion Injury in YFP-H Line Mice.

Authors:  Hideki Horiuchi; Yusuke Oshima; Tadanori Ogata; Tadao Morino; Seiji Matsuda; Hiromasa Miura; Takeshi Imamura
Journal:  Int J Mol Sci       Date:  2015-07-13       Impact factor: 5.923

5.  Age-dependent transcriptome and proteome following transection of neonatal spinal cord of Monodelphis domestica (South American grey short-tailed opossum).

Authors:  Norman R Saunders; Natassya M Noor; Katarzyna M Dziegielewska; Benjamin J Wheaton; Shane A Liddelow; David L Steer; C Joakim Ek; Mark D Habgood; Matthew J Wakefield; Helen Lindsay; Jessie Truettner; Robert D Miller; A Ian Smith; W Dalton Dietrich
Journal:  PLoS One       Date:  2014-06-10       Impact factor: 3.240

6.  VEGFR2 promotes central endothelial activation and the spread of pain in inflammatory arthritis.

Authors:  Nicholas Beazley-Long; Catherine Elizabeth Moss; William Robert Ashby; Samuel Marcus Bestall; Fatimah Almahasneh; Alexandra Margaret Durrant; Andrew Vaughan Benest; Zoe Blackley; Kurt Ballmer-Hofer; Masanori Hirashima; Richard Phillip Hulse; David Owen Bates; Lucy Frances Donaldson
Journal:  Brain Behav Immun       Date:  2018-03-14       Impact factor: 7.217

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.